Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Sylvie, Courtois"'
Autor:
Isabelle Serre, Thierry Moulin, Guillaume Charbonnier, Mariano Musacchio, Aboubaker Cherifi, Solene Moulin, Giovanni Vitale, Lionel Nace, Hamza Achit, Olivier Beaufils, Thomas Loeb, Dominique Cailloce, Thibaut Desmettre, Xavier Combes, Ariel Pablo Lebedinsky, Francis Vuillemet, Nicolas Kempf, Philippe Lemmel, Eric Schluck, Fortunato Di Caterino, Panagiotis Primikiris, Elisabeth de Bustos Medeiros, Benjamin Bouamra, Louise Bonnet, Fabrice Vuillier, Pablo A Lebedinsky, Frederico Bolognini, Elie Cohen-Khallas, Andreas Fickl, Mathilde Goudot, Sylvie Courtois, Sohrab Mostoufizadehghalamfarsa, Alessandro La Porta, Nathalie Caucheteux, Vi Tuan Hua, Mickaël Hoang, Catherine Pradeau, Jean-Marc Mene, Musa Sesay, Aymerci Rouchaud
Publikováno v:
BMJ Open, Vol 11, Iss 3 (2021)
Introduction Mechanical thrombectomy (MT) increases functional independence in patients with acute ischaemic stroke with anterior circulation large vessel occlusion (LVO), and the probability to achieve functional independence decreases by 20% for ea
Externí odkaz:
https://doaj.org/article/4dfeef05d9584c29954720683d5c58ae
Publikováno v:
Revue Neurologique. 179:S184
Autor:
Arnaud Kwiatkowski, François Sellal, Laurent Kremer, Didier Ferriby, Jérôme De Seze, Thibaut Fabacher, Sylvie Courtois, Nicolas Collongues, Hélène Zéphir, Olivier Outteryck, Jean-Claude Ongagna, Patrick Vermersch, Kévin Bigaut
Publikováno v:
Multiple Sclerosis Journal
Multiple Sclerosis Journal, SAGE Publications, 2021, 27 (5), pp.729-741. ⟨10.1177/1352458520936239⟩
Multiple Sclerosis Journal, SAGE Publications, 2021, 27 (5), pp.729-741. ⟨10.1177/1352458520936239⟩
Background: Data are needed on long-term effect of natalizumab (NTZ) in relapsing-remitting multiple sclerosis (RRMS). Objectives: To evaluate the time of onset of secondary progressive phase in patients with an RRMS treated with NTZ and to investiga
Autor:
Jérôme De Seze, Thibaut Fabacher, Sylvie Courtois, Marie-Céline Fleury, Kévin Bigaut, Guido Ahle, Laurent Kremer
Publikováno v:
Revue Neurologique. 177:S112
Introduction Une reactivation de la sclerose en plaques remittente-recurrente (SEP-RR) a ete decrite apres arret du natalizumab (NTZ). Cependant, des donnees avec des traitements recents comme l’ocrelizumab sont manquantes. Objectifs L’objectif e
Publikováno v:
Journal of Neurological Disorders. 4
The prevalence of Parkinson’s disease (PD) in the elderly population exceeds 1% according to recent reports, whereas myasthenia gravis (MG) is much rarer. The expected prevalence of the combination of MG and PD can be grossly estimated to 3 cases p
Autor:
Claire, Lecocq, Perrine, Charles, Jean-Philippe, Azulay, Wassilios, Meissner, Myriam, Rai, Karine, N'Guyen, Yann, Péréon, Nelly, Fabre, Elsa, Robin, Sylvie, Courtois, Lucie, Guyant-Maréchal, Fabien, Zagnoli, Gabrielle, Rudolf, Mathilde, Renaud, Mathieu, Sévin-Allouet, Fabien, Lesne, Nick, Alaerts, Cyril, Goizet, Patrick, Calvas, Alexandre, Eusebio, Claire, Guissart, Pascal, Derkinderen, Francois, Tison, Alexis, Brice, Michel, Koenig, Massimo, Pandolfo, Christine, Tranchant, Alexandra, Dürr, Mathieu, Anheim
Publikováno v:
Movement Disorders
Movement Disorders, Wiley, 2016, 31 (1), pp.62-69. ⟨10.1002/mds.26382⟩
Movement Disorders, Wiley, 2016, 31 (1), pp.62-69. ⟨10.1002/mds.26382⟩
International audience; BACKGROUND:Friedreich's ataxia usually occurs before the age of 25. Rare variants have been described, such as late-onset Friedreich's ataxia and very-late-onset Friedreich's ataxia, occurring after 25 and 40 years, respective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::5b6d0e579563dcf14bcb266edcaec745
https://hal.umontpellier.fr/hal-01887941
https://hal.umontpellier.fr/hal-01887941
Autor:
A. Kopf, C. Zaenker, Fleury M-C, Nicolas Collongues, A. Benoilid, Claude Gaultier, Sylvie Courtois, C. Berthe, Jean-Claude Ongagna, F. Blanc, de Seze J
Publikováno v:
Journal of Clinical & Cellular Immunology.
Background: Prolonged-release Fampridine is a selective potassium channel blocker licensed for the improvement of walking in adult patients diagnosed with multiple sclerosis (MS). The objective of this study was to evaluate the efficacy and safety of
Autor:
A. Benoilid, Jean-Claude Ongagna, Jérôme De Seze, Marie Fleury, C. Zaenker, Jean-Baptiste Chanson, Frédéric Blanc, Sylvie Courtois, Nicolas Collongues
Publikováno v:
Multiple sclerosis (Houndmills, Basingstoke, England). 19(9)
Autor:
Jérôme De Seze, Réseau Ville-Hôpital Alsacep, Jean-Claude Ongagna, C. Berthe, Sylvie Courtois, C. Zaenker, Claude Gaultier
Publikováno v:
Revue Neurologique. 171:A79
Introduction La fampridine a ete autorisee par la l’Agence europeenne du medicament (EMA) en 2012 pour soulager les trouble de la marche chez les patients atteints de sclerose en plaques. Objectifs L’objectif de cette etude etait d’evaluer la t
Autor:
V. Errami, A. Kopf, Jean-Claude Ongagna, J. de Seze, C. Zaenker, Sylvie Courtois, Claude Gaultier
Publikováno v:
Revue Neurologique. 169:A104